Global Multiple System Atrophy Therapeutics Market Research Report 2024

Report ID: 1977376 | Published Date: Jan 2025 | No. of Page: 80 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Multiple System Atrophy Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Anle-138b
        1.2.3 AZD-3241
        1.2.4 CS-10BR05
        1.2.5 NPT-20011
        1.2.6 PBT-434
        1.2.7 PD-01
    1.3 Market by Application
        1.3.1 Global Multiple System Atrophy Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Multiple System Atrophy Therapeutics Market Perspective (2018-2029)
    2.2 Multiple System Atrophy Therapeutics Growth Trends by Region
        2.2.1 Global Multiple System Atrophy Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Multiple System Atrophy Therapeutics Historic Market Size by Region (2018-2023)
        2.2.3 Multiple System Atrophy Therapeutics Forecasted Market Size by Region (2024-2029)
    2.3 Multiple System Atrophy Therapeutics Market Dynamics
        2.3.1 Multiple System Atrophy Therapeutics Industry Trends
        2.3.2 Multiple System Atrophy Therapeutics Market Drivers
        2.3.3 Multiple System Atrophy Therapeutics Market Challenges
        2.3.4 Multiple System Atrophy Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Multiple System Atrophy Therapeutics Players by Revenue
        3.1.1 Global Top Multiple System Atrophy Therapeutics Players by Revenue (2018-2023)
        3.1.2 Global Multiple System Atrophy Therapeutics Revenue Market Share by Players (2018-2023)
    3.2 Global Multiple System Atrophy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Multiple System Atrophy Therapeutics Revenue
    3.4 Global Multiple System Atrophy Therapeutics Market Concentration Ratio
        3.4.1 Global Multiple System Atrophy Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Multiple System Atrophy Therapeutics Revenue in 2022
    3.5 Multiple System Atrophy Therapeutics Key Players Head office and Area Served
    3.6 Key Players Multiple System Atrophy Therapeutics Product Solution and Service
    3.7 Date of Enter into Multiple System Atrophy Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple System Atrophy Therapeutics Breakdown Data by Type
    4.1 Global Multiple System Atrophy Therapeutics Historic Market Size by Type (2018-2023)
    4.2 Global Multiple System Atrophy Therapeutics Forecasted Market Size by Type (2024-2029)
5 Multiple System Atrophy Therapeutics Breakdown Data by Application
    5.1 Global Multiple System Atrophy Therapeutics Historic Market Size by Application (2018-2023)
    5.2 Global Multiple System Atrophy Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Multiple System Atrophy Therapeutics Market Size (2018-2029)
    6.2 North America Multiple System Atrophy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Multiple System Atrophy Therapeutics Market Size by Country (2018-2023)
    6.4 North America Multiple System Atrophy Therapeutics Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Multiple System Atrophy Therapeutics Market Size (2018-2029)
    7.2 Europe Multiple System Atrophy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Multiple System Atrophy Therapeutics Market Size by Country (2018-2023)
    7.4 Europe Multiple System Atrophy Therapeutics Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Multiple System Atrophy Therapeutics Market Size (2018-2029)
    8.2 Asia-Pacific Multiple System Atrophy Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Region (2018-2023)
    8.4 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Multiple System Atrophy Therapeutics Market Size (2018-2029)
    9.2 Latin America Multiple System Atrophy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Multiple System Atrophy Therapeutics Market Size by Country (2018-2023)
    9.4 Latin America Multiple System Atrophy Therapeutics Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Multiple System Atrophy Therapeutics Market Size (2018-2029)
    10.2 Middle East & Africa Multiple System Atrophy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Country (2018-2023)
    10.4 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 AFFiRiS AG
        11.1.1 AFFiRiS AG Company Detail
        11.1.2 AFFiRiS AG Business Overview
        11.1.3 AFFiRiS AG Multiple System Atrophy Therapeutics Introduction
        11.1.4 AFFiRiS AG Revenue in Multiple System Atrophy Therapeutics Business (2018-2023)
        11.1.5 AFFiRiS AG Recent Development
    11.2 AstraZeneca Plc
        11.2.1 AstraZeneca Plc Company Detail
        11.2.2 AstraZeneca Plc Business Overview
        11.2.3 AstraZeneca Plc Multiple System Atrophy Therapeutics Introduction
        11.2.4 AstraZeneca Plc Revenue in Multiple System Atrophy Therapeutics Business (2018-2023)
        11.2.5 AstraZeneca Plc Recent Development
    11.3 Corestem Inc
        11.3.1 Corestem Inc Company Detail
        11.3.2 Corestem Inc Business Overview
        11.3.3 Corestem Inc Multiple System Atrophy Therapeutics Introduction
        11.3.4 Corestem Inc Revenue in Multiple System Atrophy Therapeutics Business (2018-2023)
        11.3.5 Corestem Inc Recent Development
    11.4 MitoDys Therapeutics Ltd
        11.4.1 MitoDys Therapeutics Ltd Company Detail
        11.4.2 MitoDys Therapeutics Ltd Business Overview
        11.4.3 MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Introduction
        11.4.4 MitoDys Therapeutics Ltd Revenue in Multiple System Atrophy Therapeutics Business (2018-2023)
        11.4.5 MitoDys Therapeutics Ltd Recent Development
    11.5 Modag GmbH
        11.5.1 Modag GmbH Company Detail
        11.5.2 Modag GmbH Business Overview
        11.5.3 Modag GmbH Multiple System Atrophy Therapeutics Introduction
        11.5.4 Modag GmbH Revenue in Multiple System Atrophy Therapeutics Business (2018-2023)
        11.5.5 Modag GmbH Recent Development
    11.6 Neuropore Therapies Inc
        11.6.1 Neuropore Therapies Inc Company Detail
        11.6.2 Neuropore Therapies Inc Business Overview
        11.6.3 Neuropore Therapies Inc Multiple System Atrophy Therapeutics Introduction
        11.6.4 Neuropore Therapies Inc Revenue in Multiple System Atrophy Therapeutics Business (2018-2023)
        11.6.5 Neuropore Therapies Inc Recent Development
    11.7 Prana Biotechnology Ltd
        11.7.1 Prana Biotechnology Ltd Company Detail
        11.7.2 Prana Biotechnology Ltd Business Overview
        11.7.3 Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Introduction
        11.7.4 Prana Biotechnology Ltd Revenue in Multiple System Atrophy Therapeutics Business (2018-2023)
        11.7.5 Prana Biotechnology Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Multiple System Atrophy Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Anle-138b
    Table 3. Key Players of AZD-3241
    Table 4. Key Players of CS-10BR05
    Table 5. Key Players of NPT-20011
    Table 6. Key Players of PBT-434
    Table 7. Key Players of PD-01
    Table 8. Global Multiple System Atrophy Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Multiple System Atrophy Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global Multiple System Atrophy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 11. Global Multiple System Atrophy Therapeutics Market Share by Region (2018-2023)
    Table 12. Global Multiple System Atrophy Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 13. Global Multiple System Atrophy Therapeutics Market Share by Region (2024-2029)
    Table 14. Multiple System Atrophy Therapeutics Market Trends
    Table 15. Multiple System Atrophy Therapeutics Market Drivers
    Table 16. Multiple System Atrophy Therapeutics Market Challenges
    Table 17. Multiple System Atrophy Therapeutics Market Restraints
    Table 18. Global Multiple System Atrophy Therapeutics Revenue by Players (2018-2023) & (US$ Million)
    Table 19. Global Multiple System Atrophy Therapeutics Market Share by Players (2018-2023)
    Table 20. Global Top Multiple System Atrophy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple System Atrophy Therapeutics as of 2022)
    Table 21. Ranking of Global Top Multiple System Atrophy Therapeutics Companies by Revenue (US$ Million) in 2022
    Table 22. Global 5 Largest Players Market Share by Multiple System Atrophy Therapeutics Revenue (CR5 and HHI) & (2018-2023)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Multiple System Atrophy Therapeutics Product Solution and Service
    Table 25. Date of Enter into Multiple System Atrophy Therapeutics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Multiple System Atrophy Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 28. Global Multiple System Atrophy Therapeutics Revenue Market Share by Type (2018-2023)
    Table 29. Global Multiple System Atrophy Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 30. Global Multiple System Atrophy Therapeutics Revenue Market Share by Type (2024-2029)
    Table 31. Global Multiple System Atrophy Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 32. Global Multiple System Atrophy Therapeutics Revenue Market Share by Application (2018-2023)
    Table 33. Global Multiple System Atrophy Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 34. Global Multiple System Atrophy Therapeutics Revenue Market Share by Application (2024-2029)
    Table 35. North America Multiple System Atrophy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Multiple System Atrophy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Multiple System Atrophy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Multiple System Atrophy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Europe Multiple System Atrophy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 40. Europe Multiple System Atrophy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Asia-Pacific Multiple System Atrophy Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 43. Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Region (2024-2029) & (US$ Million)
    Table 44. Latin America Multiple System Atrophy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Latin America Multiple System Atrophy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Latin America Multiple System Atrophy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Middle East & Africa Multiple System Atrophy Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 50. AFFiRiS AG Company Detail
    Table 51. AFFiRiS AG Business Overview
    Table 52. AFFiRiS AG Multiple System Atrophy Therapeutics Product
    Table 53. AFFiRiS AG Revenue in Multiple System Atrophy Therapeutics Business (2018-2023) & (US$ Million)
    Table 54. AFFiRiS AG Recent Development
    Table 55. AstraZeneca Plc Company Detail
    Table 56. AstraZeneca Plc Business Overview
    Table 57. AstraZeneca Plc Multiple System Atrophy Therapeutics Product
    Table 58. AstraZeneca Plc Revenue in Multiple System Atrophy Therapeutics Business (2018-2023) & (US$ Million)
    Table 59. AstraZeneca Plc Recent Development
    Table 60. Corestem Inc Company Detail
    Table 61. Corestem Inc Business Overview
    Table 62. Corestem Inc Multiple System Atrophy Therapeutics Product
    Table 63. Corestem Inc Revenue in Multiple System Atrophy Therapeutics Business (2018-2023) & (US$ Million)
    Table 64. Corestem Inc Recent Development
    Table 65. MitoDys Therapeutics Ltd Company Detail
    Table 66. MitoDys Therapeutics Ltd Business Overview
    Table 67. MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Product
    Table 68. MitoDys Therapeutics Ltd Revenue in Multiple System Atrophy Therapeutics Business (2018-2023) & (US$ Million)
    Table 69. MitoDys Therapeutics Ltd Recent Development
    Table 70. Modag GmbH Company Detail
    Table 71. Modag GmbH Business Overview
    Table 72. Modag GmbH Multiple System Atrophy Therapeutics Product
    Table 73. Modag GmbH Revenue in Multiple System Atrophy Therapeutics Business (2018-2023) & (US$ Million)
    Table 74. Modag GmbH Recent Development
    Table 75. Neuropore Therapies Inc Company Detail
    Table 76. Neuropore Therapies Inc Business Overview
    Table 77. Neuropore Therapies Inc Multiple System Atrophy Therapeutics Product
    Table 78. Neuropore Therapies Inc Revenue in Multiple System Atrophy Therapeutics Business (2018-2023) & (US$ Million)
    Table 79. Neuropore Therapies Inc Recent Development
    Table 80. Prana Biotechnology Ltd Company Detail
    Table 81. Prana Biotechnology Ltd Business Overview
    Table 82. Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Product
    Table 83. Prana Biotechnology Ltd Revenue in Multiple System Atrophy Therapeutics Business (2018-2023) & (US$ Million)
    Table 84. Prana Biotechnology Ltd Recent Development
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Multiple System Atrophy Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Multiple System Atrophy Therapeutics Market Share by Type: 2022 VS 2029
    Figure 3. Anle-138b Features
    Figure 4. AZD-3241 Features
    Figure 5. CS-10BR05 Features
    Figure 6. NPT-20011 Features
    Figure 7. PBT-434 Features
    Figure 8. PD-01 Features
    Figure 9. Global Multiple System Atrophy Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Multiple System Atrophy Therapeutics Market Share by Application: 2022 VS 2029
    Figure 11. Hospital Case Studies
    Figure 12. Clinic Case Studies
    Figure 13. Others Case Studies
    Figure 14. Multiple System Atrophy Therapeutics Report Years Considered
    Figure 15. Global Multiple System Atrophy Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 16. Global Multiple System Atrophy Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Multiple System Atrophy Therapeutics Market Share by Region: 2022 VS 2029
    Figure 18. Global Multiple System Atrophy Therapeutics Market Share by Players in 2022
    Figure 19. Global Top Multiple System Atrophy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple System Atrophy Therapeutics as of 2022)
    Figure 20. The Top 10 and 5 Players Market Share by Multiple System Atrophy Therapeutics Revenue in 2022
    Figure 21. North America Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. North America Multiple System Atrophy Therapeutics Market Share by Country (2018-2029)
    Figure 23. United States Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Multiple System Atrophy Therapeutics Market Share by Country (2018-2029)
    Figure 27. Germany Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Asia-Pacific Multiple System Atrophy Therapeutics Market Share by Region (2018-2029)
    Figure 35. China Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Japan Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. South Korea Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Southeast Asia Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. India Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Australia Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Latin America Multiple System Atrophy Therapeutics Market Share by Country (2018-2029)
    Figure 43. Mexico Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Brazil Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East & Africa Multiple System Atrophy Therapeutics Market Share by Country (2018-2029)
    Figure 47. Turkey Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Saudi Arabia Multiple System Atrophy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. AFFiRiS AG Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2018-2023)
    Figure 50. AstraZeneca Plc Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2018-2023)
    Figure 51. Corestem Inc Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2018-2023)
    Figure 52. MitoDys Therapeutics Ltd Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2018-2023)
    Figure 53. Modag GmbH Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2018-2023)
    Figure 54. Neuropore Therapies Inc Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2018-2023)
    Figure 55. Prana Biotechnology Ltd Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2018-2023)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AFFiRiS AG
AstraZeneca Plc
Corestem Inc
MitoDys Therapeutics Ltd
Modag GmbH
Neuropore Therapies Inc
Prana Biotechnology Ltd
Frequently Asked Questions
Multiple System Atrophy Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Multiple System Atrophy Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Multiple System Atrophy Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports